Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the incidence of nausea, vomiting, need for rescue
medication, prolonged PACU time, and unplanned hospital admission in patients with high risk
for post-operative nausea and vomiting (PONV) treated with oral aprepitant with or without
transdermal scopolamine preoperatively.